result roughli line think
spend tax outlook impli ep declin possibl yr/yr
concern competit price unresolv pt
relief yet result saw benefit stabl
strong scanner sale drove beat vs consensu qr/qr volum
trend north american ortho slow promot pull volum
acceler spend higher tax rate pressur ep
outlook na ortho volum growth actual stronger
pull forward promot drag step-down
na ortho util disproven marker structur slow
stronger result futur period margin pressur new rep add
shift spend new facil oper expens capit expens
like view long-term posit algn past move
grow commerci capac all-in increment concern
post result guid investor debat around
concentr competit price present result seem
unlik quash question point multipl layer pressur
margin detail like pressur consensu ep
guidanc bigger pictur top line algn full year
guidanc assum major impact new competit emb
observ macro slow assum modest impact new rep hire
yet call volum deceler full year vs
slower vs agre deceler like though
guidanc conserv model vs guidanc
assum at-hom product launch emerg
flag recent survey align survey neg posit
stmn see slower shift market bracket align
margin top larger base impli market growth slow regardless
competit dynam algn guidanc actual fall growth level
survey suggest like us beg question
variabl undermodel might heavi dose conservat
guid competit macro market matur remain potenti growth
headwind may fulli account outlook
margin math messi weve tax rate concern
guid margin ebit line sequenti
higher freight cost bp case complex fx poor fix cost absorpt
began product china new rep hire bp elev spend
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
legal cost oper transit bp explain move
suggest underli trend stabl market like struggl digest
optic meaning uncertainti point bridg see
reason make meaning chang medium term margin think
recal guid dramat margin compress also roughli
beat ebit margin guidanc guidanc
assum ebit margin trend improv year tax rate
pressur howev structur guidanc rate go
higher
lower estim acceler spend expect higher tax rate
pt make chang estim reflect slightli lower
expect case volum margin lower revenu expect
decreas oper margin rais tax rate
previou result ep chang
note post ep chang see key driver ep
pressur acceler sale hire restructur spend one-tim
natur pt base upon yield
estim impli price-to-earnings multipl current multipl
ntm price-to-earnings target impli multipl higher reflect recent increas
market multipl roughli sinc outlook offset
lower estim lower less post
strong market augment distribut major competitor emerg
macro trend improv expect us europ at-hom
align market grow fast predic aesthet market key
beneficiari share
underli trend improv top-line growth moder
tough comp align abl retain key share among high-
volum ortho north america increas digit
intern sale continu grow clip medium term ep
growth compound-annual-growth-rate captur emerg at-hom align
opportun
competit littl tougher macro environ slow
aggress promot competit product activ us europ
us high-end spend growth stabil recoveri post-crisi
investor turn attent ip expir npv impact
addit competit at-hom align opportun emerg slowli
captur share
invisalign growth expect continu
assum increment competit despit
potenti entrant near term
new featur market support
differenti barrier entri
consum sensit remain high
invisalign typic target toward case
discretionari
interoper intraor scanner
includ siro omnicam expand
potenti custom base
appear like key beneficiari
emerg at-hom align opportun
could size core
invisalign consum appeal substanti
clear align far less disrupt
patient activ tradit brace
align offer wide array featur set
orient vari degre physician
profici patient age case sever
increas mix digit case submiss
current orthodont total
time half
inflect discretionari spend
local facil salesforc emea
apac
risk achiev price
spend us abroad
new competit entri aggress
price
loss tax deduct
exhibit case volum growth acceler new high
yr-yr chang shipment
yr-yr chang us
number custom order
exhibit revenu growth rel profit growth
revenu oper profit trend
exhibit chang forecast
sale
sale
sale
sale
sale
sale
million except ep
scanner servic
compani data morgan stanley research
valuat risk
exhibit ev/sal valuat vs fast growth compani
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
price target price base yield
estim impli price-to-earnings multipl current multipl ntm
price-to-earnings see acceler ep growth ep compound-annual-growth-rate
rang busi reap benefit agreement sdc increas
digit technolog among dentist intern market penetr
risk price target includ discretionari consum spend trend
competit entri market
compani data morgan stanley research
compani data morgan stanley research
